Jafron Biomedical Co.,Ltd.

XSEC:300529 Stock Report

Market Cap: CN¥23.3b

Jafron BiomedicalLtd Past Earnings Performance

Past criteria checks 5/6

Jafron BiomedicalLtd's earnings have been declining at an average annual rate of -2.5%, while the Medical Equipment industry saw earnings growing at 6.1% annually. Revenues have been growing at an average rate of 7.8% per year. Jafron BiomedicalLtd's return on equity is 24.1%, and it has net margins of 30.6%.

Key information

-2.5%

Earnings growth rate

-2.5%

EPS growth rate

Medical Equipment Industry Growth16.0%
Revenue growth rate7.8%
Return on equity24.1%
Net Margin30.6%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Jafron BiomedicalLtd makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

XSEC:300529 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 242,632804880244
30 Jun 242,406711822244
31 Mar 242,094525798246
31 Dec 231,922436784245
30 Sep 231,952440826268
30 Jun 231,949419855269
31 Mar 232,367751862267
01 Jan 232,491890837254
30 Sep 222,9191,207843240
30 Jun 223,0411,325839222
31 Mar 222,7941,249750194
01 Jan 222,6751,197736174
30 Sep 212,4171,111665129
30 Jun 212,2691,055634101
31 Mar 212,15197463889
31 Dec 201,95187558881
30 Sep 201,77678058769
30 Jun 201,64370655769
31 Mar 201,51662654167
31 Dec 191,43257153968
30 Sep 191,29051448262
30 Jun 191,21949844756
31 Mar 191,10544241450
31 Dec 181,01740238846
30 Sep 1892538733841
30 Jun 1884634530447
31 Mar 1877731529036
31 Dec 1771828427727
30 Sep 1766226624617
30 Jun 176122512400
31 Mar 175662152250
31 Dec 165442022200
30 Sep 165372042150
30 Jun 165472092170
31 Mar 165322102080
31 Dec 155092001940
31 Dec 143711601390
31 Dec 133041271090

Quality Earnings: 300529 has high quality earnings.

Growing Profit Margin: 300529's current net profit margins (30.6%) are higher than last year (22.5%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 300529's earnings have declined by 2.5% per year over the past 5 years.

Accelerating Growth: 300529's earnings growth over the past year (82.9%) exceeds its 5-year average (-2.5% per year).

Earnings vs Industry: 300529 earnings growth over the past year (82.9%) exceeded the Medical Equipment industry -8.8%.

Return on Equity

High ROE: 300529's Return on Equity (24.1%) is considered high.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/19 22:36
End of Day Share Price 2024/12/19 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Jafron Biomedical Co.,Ltd. is covered by 9 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Sophia ZhangChina Stock Investment Research Co. Ltd. (GZ500..com)
Shuo SongCitic Securities Co., Ltd.
Xiao Wei LinEverbright Securities Co. Ltd.